Lottery.com Inc
Change company Symbol lookup
Select an option...
LTRY Lottery.com Inc
RCLF Rosecliff Acquisition Corp I
SSYS Stratasys Ltd
GRN iPath? Series B Carbon ETN
RCKTF Rock Tech Lithium Inc
SOND Sonder Holdings Inc
PTE PolarityTE Inc
CTRA Coterra Energy Inc
L Loews Corp
HSY Hershey Co
Go

*Nasdaq FSI: *Deficient and Delinquent: Issuer Failed to Meet NASDAQ Continued Listing Requirements, and Missed Regulatory Filing Deadline

Company profile

Lottery.com Inc. is a technology company that is a provider of domestic and international lottery products and services. It is engaged in mobile and online platforms that enable players located in the United States and internationally to remotely purchase legally sanctioned lottery games. The Company offers the platform through the Lottery.com app and its Websites to users located in the United States. and international jurisdictions where the sale of lottery games is legal, and its services are enabled for the remote purchase of legally sanctioned lottery games (B2C Platform). It offers an internally developed, created and operated business-to-business application programming interface (API) of the platform to enable commercial partners in permitted the United States and international jurisdictions to purchase certain legally operated lottery games from the Company and resell them to users located within their respective jurisdictions (B2B API). It also delivers global lottery data.

Price
Delayed
$0.2486
Day's Change
0.0094 (3.95%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.2493
Day's Low
0.2319
Volume
(Average)

Today's volume of 29,172 shares is on pace to be in-line with LTRY's 10-day average volume of 429,844 shares.

29,172

Evofem Biosciences to Host Investor Call on Thursday, August 11, 2022

8:23 pm ET August 10, 2022 (PR Newswire) Print

Conference Call Scheduled for 5:00 p.m. ET --

Evofem Biosciences, Inc., (EVFM) will hold an investor call as follows:

https://mma.prnewswire.com/media/780907/Evofem_Biosciences_Logo.jpg

Date:                        Thursday, August 11, 2022
Time:                        5:00 p.m. ET (2:00 p.m. PT)
Live call:                   (877) 445-9755 (U.S. toll-free) or
                             (201) 493-6744
Webcast (live and archived): https://evofem.investorroom.com/Update or
                             https://www.webcast-eqs.com/register/evofem2022811/en

Please connect to the webcast at least 15 minutes prior to the start of the call to download any software that may be required. If participating by phone, please dial in approximately 15 minutes prior to the start of the call.

About Evofem BiosciencesEvofem Biosciences, Inc., (EVFM) is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from chlamydia and gonorrhea. The Company's first FDA-approved product, Phexxi(R) (lactic acid, citric acid and potassium bitartrate), is a hormone-free, on-demand prescription contraceptive vaginal gel. It comes in a box of 12 pre-filled applicators and is applied 0-60 minutes before each act of sex. The Company expects to report top-line data in October 2022 from its registrational Phase 3 EVOGUARD clinical trial evaluating Phexxi for two potential new indications - prevention of chlamydia and prevention of gonorrhea in women. Learn more at phexxi.com and evofem.com.

Phexxi(R) is a registered trademark of Evofem Biosciences, Inc.

Investor Relations ContactAmy RaskopfEvofem Biosciences, Inc.araskopf@evofem.com (917) 673-5775

https://c212.net/c/img/favicon.png?sn=LA42167&sd=2022-08-10

View original content to download multimedia:https://www.prnewswire.com/news-releases/evofem-biosciences-to-host-investor-call-on-thursday-august-11-2022-301603911.html

SOURCE Evofem Biosciences, Inc.

https://rt.prnewswire.com/rt.gif?NewsItemId=LA42167&Transmission_Id=202208102023PR_NEWS_USPR_____LA42167&DateId=20220810

comtex tracking

COMTEX_412033151/1005/2022-08-10T20:23:47

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.